US 11898165
Engineered host cells and methods of use thereof
granted A61KA61K35/17A61K38/00
Quick answer
US patent 11898165 (Engineered host cells and methods of use thereof) held by MiNK Therapeutics, Inc. expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MiNK Therapeutics, Inc.
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/17, A61K38/00